RHBC
CRNC icon

R.H. Bluestein & Co’s Cerence CRNC Stock Holding History

R.H. Bluestein & Co’s Portfolio CRNC Stock Details CRNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,240
Closed -$632K – 392
2021
Q4 		$632K Buy
8,240
+6,000
+268% +$529K 0.02% 178
2021
Q3 		$215K Hold
2,240
– – 0.01% 392
2021
Q2 		$239K Buy
+2,240
New +$220K 0.01% 380

Other funds holding CRNC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

R.H. Bluestein & Co's CRNC Position: Q1 2022 in Review

R.H. Bluestein & Co sold out of Cerence (CRNC) in Q1 2022, closing a stake of 8,240 shares — an estimated $632K sold.

R.H. Bluestein & Co first reported a position in CRNC in Q2 2021 and held it in 3 quarters. The position peaked at $632K in Q4 2021. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

  • R.H. Bluestein & Co reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
  • R.H. Bluestein & Co sold 8,240 Cerence shares in Q1 2022, an estimated $632K.
  • R.H. Bluestein & Co first reported a position in Cerence in Q2 2021 and held it in 3 quarters.
  • R.H. Bluestein & Co's Cerence position peaked at $632K in Q4 2021.
  • 286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on R.H. Bluestein & Co's 13F filing for Q1 2022, filed 11 May 2022.